MRC Postgraduate Day MRC Postgraduate Day 19 June 2014 - Graham Kerr Building, University of Glasgow 19 June 2014 - Graham Kerr Building, University of Glasgow 12.00 – 12.15 Registration and poster set up
12.15 – 12.20 Professor Jeremy Mottram, Dean of Graduate Studies, Registration and poster set up College of Medical, Veterinary and Life Sciences
12.00 – 12.15 12.15 – 12.20
Professor Jeremy Mottram, Dean of Graduate Studies,
talks’ on posters 12.20 – 12.45 Student College of‘turbo Medical, Veterinary and Life Sciences 12.45 – 13.45 Lunch Student and ‘turboposter talks’ onviewing/judging posters
12.20 – 13.30
13.45 – 14.45 PhD student presentations
13.30 – 14.30 14.30 – 15.15
Lunch and poster viewing/judging
00.00
Despoina Aslanoglou – "Oligomerisation of Muscarinic Acetylcholine receptors: Ligand regulation of hM2WT and hM3RASSL hetero- and homooligomerisation" XXXX – “XXXXX
00.00
XXXXXX” XXXXX – “XXXXX
13.45
PhD student presentations
14.00 14.15 14.30 00.00
Amy Goundry – "Leishmania virulence factors: Inhibitors of serine peptidases"
William Harvey – "Using genetic information to understand antigenic variation among influenza viruses"
XXXXXXX XXXXX” Pearl–Lee – "The XXXXX “XXXXXX
regulation of TIGAR, a p53 target gene"
XXXXX”
14.45 – 15.15 Professor Robert Install – “Research Integrity: What’s the fuss?” 00.00 XXXXX – “XXXXXX (Institute of Cancer Sciences) Coffee Robert Install – ““Research Integrity; what’s 15.15 – 15.30 Professor
15.15 – 15.45
the fuss?” (Institute of Cancer Sciences)
15.30 – 15.50 Ms Simone Bryan – "Where are you going and how will you get there? Career opportunities for Coffee 15.35 – 15.55 MRC students" (Panel Manager, MRC Head Office) Ms Simone Bryan – (Panel Manager, MRC Head Office) 15.55 – 16.15 IainIain McInnes – “Can–academics participate participate in drug 16.15 – –16.35 Professor McInnes “Can academics in Drug Discovery? 15.50 16.10 Professor discovery?” (Institute of Infection,(Institute Immunity and Inflammation) of Infection, Immunity and Inflammation)
16.10 16.30 Dr “The making of a Drug: Opportunities and Challenges" RoseMaciewicz Maciewicz – making Dr Rose – “The of a Drug: 16.35 – – 16.55 opportunities and challenges" (Vice President, Head of Strategy, AstraZeneca) (Vice President, Head of Strategy, AstraZeneca)
16.30 – 16.50 Concluding remarks and prize awards 16.55 – 17.15
Concluding remarks and prize awards
17.15 – 18.30
Refreshments and networking
16.50 – 18.00 Refreshments and networking